Literature DB >> 27357703

Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Toral Zaveri1,2, Cordelia A Running1,2, Lahari Surapaneni2, Gregory R Ziegler2, John E Hayes3,4.   

Abstract

Vaginal microbicides are a promising means to prevent the transmission of HIV, empowering women by putting protection under their control. We have been using gel technology to develop microbicides in the intermediate texture space to overcome shortcomings of current solid and liquid forms. We recently formulated semisoft ovules from mixed polymer combinations of carrageenan and Carbopol 940P to overcome some of the flaws with our previous generation of formulations based solely on carrageenan. To determine the user acceptability of the reformulated gels, women first evaluated intact semisoft ovules before evaluating ovules that had been subjected to mechanical crushing to simulate samples that represent post-use discharge. Women then evaluated combinations of intact and discharge samples to understand how ovule textures correlated with texture of the resulting discharge samples. Carbopol concentration directly and inversely correlated with willingness to try for discharge samples and intact samples, respectively. When evaluating intact samples, women focused on the ease of inserting the product and preferred firmer samples; conversely, when evaluating discharge samples, softer samples that resulted in a smooth paste were preferred. Significant differences between samples were lost when evaluating pairs as women made varying trade-offs between their preference for ease of inserting intact ovules and acceptability of discharge appearance. Evaluating samples that represent different stages of the use cycle reveals a more holistic measure of product acceptability. Studying sensory acceptability in parallel with biophysical performance enables an iterative design process that considers what women prefer in terms of insertion as well as possibility of leakage.

Entities:  

Keywords:  Acceptability; Carbopol 940; Carrageenan; Formulation development; HIV; Vaginal microbicides

Mesh:

Substances:

Year:  2016        PMID: 27357703      PMCID: PMC5011315          DOI: 10.1007/s13346-016-0309-8

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  39 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Julia G Shaw; E Milu Kojic; Patrick F Kiser; David R Friend; David F Katz
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

4.  Microbicide acceptability among female sex workers in Beijing, China: results from a pilot study.

Authors:  Lin Han; Fan Lv; Peng Xu; Guolei Zhang; Naomi S Juniper; Zhenglai Wu
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

5.  Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Authors:  Salim S Abdool Karim; Angela D M Kashuba; Lise Werner; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

6.  Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.

Authors:  Annalene M Nel; Lynne B Mitchnick; Peter Risha; Lungwani Tyson Makoye Muungo; Pamela M Norick
Journal:  J Womens Health (Larchmt)       Date:  2011-07-20       Impact factor: 2.681

7.  The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Authors:  Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2003-09       Impact factor: 2.681

8.  "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.

Authors:  Jacob J van den Berg; Rochelle K Rosen; Dana E Bregman; Lara A Thompson; Kathleen M Jensen; Patrick F Kiser; David F Katz; Karen Buckheit; Robert W Buckheit; Kathleen M Morrow
Journal:  AIDS Behav       Date:  2014-05

9.  The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development.

Authors:  Kate Morrow Guthrie; Sara Vargas; Julia G Shaw; Rochelle K Rosen; Jacob J van den Berg; Patrick F Kiser; Karen Buckheit; Dana Bregman; Lara Thompson; Kathleen Jensen; Todd Johnson; Robert W Buckheit
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

10.  Development and characterization of bioadhesive gel of microencapsulated metronidazole for vaginal use.

Authors:  Nayak Bhabani Shankar; Rout Prasant Kumar; Nayak Udaya Kumar; Bhowmik Benoy Brata
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

View more
  2 in total

Review 1.  Carrageenan: Drug Delivery Systems and Other Biomedical Applications.

Authors:  Edisson-Mauricio Pacheco-Quito; Roberto Ruiz-Caro; María-Dolores Veiga
Journal:  Mar Drugs       Date:  2020-11-23       Impact factor: 5.118

2.  Design aspects of vaginal applicators that influence acceptance among target users.

Authors:  Alyssa J Bakke; Toral Zaveri; Molly J Higgins; Gregory R Ziegler; John E Hayes
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.